Literature DB >> 16836720

Ventricular tachycardia originating from the epicardium identified by intracoronary mapping using a PTCA guidewire.

Koji Kumagai1, Atsushi Takahashi, Yasuteru Yamauchi, Kazutaka Aonuma.   

Abstract

We report a case in which endocardial radiofrequency (RF) ablation guided by unipolar intracoronary mapping using a guidewire was an effective therapy for treating VT originating from an epicardial site of the left ventricle. A 55-year-old man with dilated cardiomyopathy was referred for treatment of refractory sustained monomorphic VT. The earliest unipolar electrogram with a near-perfect pace map was identified at segment #8 of the left anterior descending artery utilizing a guidewire through a microtube catheter during the VT. VT was terminated by an endocardial RF application at an upper midventricular septal site that did not have a good pacemap or the earliest electrogram, and that was the most adjacent anatomical endocardial site to the guidewire tip. No VT was clinically observed during a follow up period of 14 months.

Entities:  

Mesh:

Year:  2006        PMID: 16836720     DOI: 10.1111/j.1540-8167.2006.00357.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  3 in total

Review 1.  Optimal ablation strategies for different types of ventricular tachycardias.

Authors:  Takumi Yamada; G Neal Kay
Journal:  Nat Rev Cardiol       Date:  2012-05-29       Impact factor: 32.419

2.  Guidewire ablation of epicardial ventricular arrhythmia within the coronary venous system: A case report.

Authors:  Fengqi Xuan; Ming Liang; Sainan Li; Zhongyin Zuo; Yaling Han; Zulu Wang
Journal:  HeartRhythm Case Rep       Date:  2021-12-30

3.  Intra-coronary guidewire mapping-a novel technique to guide ablation of human ventricular tachycardia.

Authors:  Oliver R Segal; Tom Wong; Anthony W C Chow; Julian W E Jarman; Richard J Schilling; Vias Markides; Nicholas S Peters; D Wyn Davies
Journal:  J Interv Card Electrophysiol       Date:  2007-04-27       Impact factor: 1.759

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.